måndag den 29 april

Nya PPM: Risk för småbolagsstök

Ellinor Beckett
Stockholmsbörsen
(), idag
-
-

CombiGene
BioStock: CombiGene’s scientific founders on the agreement with Spark (Cision)

2021-10-26 09:06
Recently, gene therapy company CombiGene signed an exclusive global license agreement for their gene therapy candidate CG01 with Spark Therapeutics. The deal is potentially worth $328.5 million excluding royalties. Much has happened since CombiGene was formed and BioStock turned to the scientific founders Professor Merab Kokaia and Associate Professor David Woldbye, for a comment on the company’s development.

Read the full interview with Merab Kokaia and David Woldbye at biostock.se:

https://www.biostock.se/en/2021/10/combigenes-scientific-founders-on-the-agreement-with-spark/

This is a pressrelease from BioStock - Connecting Innovation & Capital. https://www.biostock.se/


Combigene - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -